Cava has been reporting high sales and comparable sales growth. It has been profitable since its first quarter as a public company in 2023. Cava stock trades at a high valuation. Cava is one of ...

[13] reported 3 cases of SVC syndrome due to SVC stenosis. The authors did not comment as to whether the ablation procedure itself was a risk factor for development of the syndrome, but the study ...

CAVA has the potential to become a household name over the long run, but its current stock valuation is extremely high. We conducted a 20-year DCF analysis on CAVA, using very generous assumptions ...